Results 241 to 250 of about 26,812 (287)

HPV‐Adjusted Feature Screening With FDR Control in Head and Neck Cancer

open access: yesBiometrical Journal, Volume 68, Issue 3, June 2026.
ABSTRACT Human papillomavirus (HPV) is a well‐established prognostic factor in head and neck (HN) cancer, with HPV‐positive patients exhibiting markedly better survival outcomes compared to their HPV‐negative counterparts. While advances in (cancer) genomics have been pivotal to precision medicine, existing gene screening methods for identifying ...
Atika Farzana Urmi   +2 more
wiley   +1 more source

Isolated dysphagia masking myasthenia gravis diagnosis. [PDF]

open access: yesArq Neuropsiquiatr
Lusvarghi IL   +5 more
europepmc   +1 more source

Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022. [PDF]

open access: yesCA Cancer J Clin
Rumgay H   +12 more
europepmc   +1 more source

Association of human papillomavirus (HPV) infection with the occurrence of second neoplasms and their prognostic impact in patients with oropharyngeal carcinoma

Acta Otorrinolaringologica (English Edition)
This study analyses the incidence of second neoplasms in patients with oropharyngeal carcinoma according to human papillomavirus (HPV) status and its impact on survival.A retrospective analysis of 583 patients with oropharyngeal cancer treated between 1991 and 2023 was performed.
Cristina Valero   +2 more
exaly   +3 more sources

The possibilities of accompanying therapy for malignant oropharyngeal neoplasms

P.A. Herzen Journal of Oncology, 2023
Objective. To evaluate the efficiency of incorporating remaxol into the accompanying therapy regimen for patients with malignant oropharyngeal neoplasms with the manifestations of toxic reactions to etiotropic treatment. Subjects and methods. The data of 104 patients (88 men and 16 women) with R-negative oropharyngeal cancer (T3-4N0-3M0) were analyzed.
M.I. Ivanova   +5 more
openaire   +1 more source

Home - About - Disclaimer - Privacy